Physician profile
Heidi Ann Johnson
NPI 1194876318
$1,404.58
in general payments reported to CMS, 2019-2025
18 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $164 · 2021: $202 · 2022: $87.45 · 2023: $61.70 · 2024: $132 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $239.75 | 2019-2020 | |
| Novo Nordisk INC | $223.14 | 2019-2022 | |
| Abbvie INC. | $196.25 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $158.82 | 2019-2023 | Breztri |
| Biohaven Pharmaceuticals, INC. | $144.54 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.10 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.99 | 2019 | |
| Lilly USA, LLC | $51.14 | 2019 | |
| Pfizer INC. | $32.04 | 2019 | |
| Astellas Pharma US INC | $23.84 | 2019 | |
| Ibsa Pharma INC. | $22.18 | 2019 | |
| Exact Sciences Corporation | $17.20 | 2025 | The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $13.41 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.24 | 2019 | |
| Amgen INC. | $12.75 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.32 | 2019 | |
| Glaxosmithkline, LLC. | $12.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.